Drug shows promise in coronavirus fight
One vial of remdesivir, which is one of the most highly anticipated drugs being tested against the new coronavirus. It is yielding positive results in a large-scale US government trial. – AFP pic, April 30, 2020.
US scientists yesterday hailed a potential breakthrough in the coronavirus fight as a trial showed patients responding to an antiviral drug, fuelling global hopes for a return to normal. The medical news was enough to propel a rebound on Wall Street even after data showed the pandemic has plunged the United States into its worst economic slump in a decade and Germany predicted its biggest recession since the aftermath of World War II.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one week free access!
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Arthritis drug shows ‘significant’ promise in severe Covid-19 cases, says study | The Malaysian InsightTreatment which suppresses immune response could prevent extreme inflammation leading to death.
Read more »
Venezuelan indicted in US for drug trafficking made oil minister | The Malaysian InsightTareck El Aissami tasked with ‘restructuring and reorganisation’ of nation’s crippled oil industry, says president.
Read more »
Hopes for Covid-19 drug dashed in virus trial | The Malaysian InsightArthritis drug does not attack Covid-19 but inhibits cytokine storm.
Read more »
Four Asean nations among 38 to get Avigan drug from Japan for clinical trialBANGKOK (The Nation/ANN): Japan is preparing to send Avigan, a drug used for treating influenza, to 38 countries this week, with four Asean countries -- the Philippines, Malaysia, Indonesia and Myanmar -- joining the trial for Covid-19 patients.
Read more »
Closely watched arthritis drug disappoints in Covid-19 trial | Malay MailWASHINGTON, April 28 — An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said yesterday. Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus but instead...
Read more »
Closely watched arthritis drug disappoints in Covid-19 trialWASHINGTON (AFP): An arthritis drug that was being closely watched for its potential use against Covid-19 has delivered disappointing results in clinical trials, its makers said on Monday (April 27).
Read more »